Skip to main content

Notice of Funding Opportunity: Catalyst for Infant Health Equity

HUDUSER Header logo
background icon
Twitter icon

background icon

More Share Options
background icon
Like This on Facebook

February 09, 2021  

Notice of Funding Opportunity: Catalyst for Infant Health Equity

PD&R is sharing this Notice of Funding Opportunity from our colleagues at the Health Resources and Services Administration (HRSA), an agency of the U.S. Department of Health and Human Services. HRSA is now accepting applications for the fiscal year 2022 Catalyst for Infant Health Equity program. The purpose of this new funding opportunity is to support the implementation of existing action plans that apply data-driven policy and innovative systems strategies to reduce infant mortality (IM) disparities in a specific county/jurisdiction. The goals of the Catalyst for Infant Health Equity program are twofold: 1) to continue reducing overall IM rates in the United States, and 2) to decrease and ultimately eliminate disparities in IM across racial/ethnic groups by achieving steeper declines for groups with highest rates. To maximize impact on disparities in infant mortality rates at the national level, counties/jurisdictions with larger numbers of excess infant deaths will be considered priority areas. The Catalyst for Infant Health Equity program is open to applicants from domestic or private entities, community-based organizations, tribes and tribal organizations. HRSA anticipates that Catalyst awards will accelerate the reduction of IM disparities and excess infant deaths by supporting policy and systems changes that improve conditions to promote equity.

The anticipated project start date is September 1, 2022. Letters of Intent to apply are requested by February 18, 2022.

Applications are due April 19, 2022. More information is available in the NOFO:

For more information, please contact the Division of Healthy Start and Perinatal Services as

Learn More



HUD USER | P.O. Box 23268, Washington, DC 20026-3268
Toll Free: 1-800-245-2691 | TDD: 1-800-927-7589
Local: 1-202-708-3178 | Fax: 1-202-708-9981